Header Logo

Connection

DANIEL J BOOSER to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications DANIEL J BOOSER has written about TOR Serine-Threonine Kinases.
DANIEL J BOOSER
Connection Strength
0.015
TOR Serine-Threonine Kinases
  1. Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy. J Clin Oncol. 2011 Aug 10; 29(23):3126-32.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.